Endocrinopathies induced by immune checkpoint inhibitors: the need for clear endocrine diagnosis

Lancet Oncol. 2021 Jul;22(7):905-907. doi: 10.1016/S1470-2045(21)00305-3.

Authors

Ruth Percik¹, James Larkin², Daniel L Morganstein³

Affiliations

¹ Department of Endocrinology, Diabetes and Metabolism, Sheba Medical Centre, Israel.
² Skin Unit, Royal Marsden Hospital, London, UK.
³ Skin Unit, Royal Marsden Hospital, London, UK; Department of Endocrinology, Chelsea and Westminster Hospital, London SW10 9NH, UK. Electronic address: d.morganstein@ic.ac.uk.

PMID: 34197741
DOI: 10.1016/S1470-2045(21)00305-3

No abstract available

MeSH terms

Consensus
Endocrine System Diseases / chemically induced*
Endocrine System Diseases / classification
Endocrine System Diseases / diagnosis*
Humans
Immune Checkpoint Inhibitors / adverse effects*
Predictive Value of Tests
Terminology as Topic*

Substances

Immune Checkpoint Inhibitors